• 1. An approach to 7-aza-1-phosphanorbornane complexes: strain promoted rearrangement of 1-iminylphosphirane complexes and cycloaddition with olefins?
  Yang Xu,Min Wang,Donghui Wei,Rongqiang Tian,Zheng Duan,Fran?ois Mathey Dalton Trans., 2019,48, 5523-5526
• 2. An antioxidative galactomannan extracted from Chinese Sesbania cannabina enhances immune activation of macrophage cells?
  Chongyang Zhu,Xiaojia Bian,Xin Jia,Ning Tang,Yongqiang Cheng Food Funct., 2020,11, 10635-10644
• 3. An investigation into the origin of variations in photovoltaic performance using D–D–π–A and D–A–π–A triphenylimidazole dyes with a copper electrolyte?
  Govind Reddy Mol. Syst. Des. Eng., 2021,6, 779-789
• 4. Acetylcholinesterase amperometric detection system based on a cobalt(II) tetraphenylporphyrin-modified electrode
  Analyst, 1996,121, 1123-1126
• 5. An integrated droplet-digital microfluidic system for on-demand droplet creation, mixing, incubation, and sorting?
  Lab Chip, 2019,19, 524-535

Professional Introduction to 3-Pyridinemethanol, 5-amino-4-methyl- (CAS No. 1384972-94-4)

3-Pyridinemethanol, 5-amino-4-methyl-, identified by its Chemical Abstracts Service (CAS) number 1384972-94-4, is a heterocyclic organic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal research. This compound belongs to the pyridine derivatives, a class of molecules widely recognized for their diverse biological activities and potential therapeutic applications. The structural features of 3-Pyridinemethanol, 5-amino-4-methyl-, particularly the presence of both an amino group and a hydroxymethyl substituent on the pyridine ring, make it a versatile scaffold for further chemical modifications and functionalization, enabling the development of novel bioactive molecules.

The 5-amino and 4-methyl substituents in the molecular structure contribute to the unique electronic and steric properties of this compound. The amino group can participate in hydrogen bonding interactions, which are crucial for binding to biological targets such as enzymes and receptors. Meanwhile, the methyl group at the 4-position introduces steric hindrance, which can influence the compound's solubility, metabolic stability, and binding affinity. These structural attributes have made 3-Pyridinemethanol, 5-amino-4-methyl- a valuable intermediate in the synthesis of more complex pharmacophores.

In recent years, there has been growing interest in exploring the pharmacological potential of pyridine-based compounds due to their well-documented role in drug discovery. Studies have demonstrated that pyridine derivatives exhibit a wide range of biological activities, including antimicrobial, anti-inflammatory, anticancer, and neuroprotective effects. The specific arrangement of functional groups in 3-Pyridinemethanol, 5-amino-4-methyl- positions it as a promising candidate for further investigation in these areas.

One of the most compelling aspects of 3-Pyridinemethanol, 5-amino-4-methyl- is its utility as a building block for the synthesis of more intricate molecules. Researchers have leveraged its reactive sites to develop novel analogs with enhanced biological activity. For instance, by introducing additional substituents or modifying existing ones, chemists can fine-tune the pharmacokinetic properties and target specificity of derived compounds. This flexibility has been particularly valuable in the development of small-molecule inhibitors targeting enzyme-catalyzed reactions relevant to human health and disease.

The pharmaceutical industry has been particularly keen on exploring derivatives of pyridine due to their historical success in drug development. Several FDA-approved drugs contain pyridine moieties as key structural components, underscoring their importance in medicinal chemistry. The compound 3-Pyridinemethanol, 5-amino-4-methyl-, with its strategic placement of functional groups, aligns well with this trend and offers a rich platform for innovation.

Recent advancements in computational chemistry have further accelerated the discovery process for compounds like 3-Pyridinemethanol, 5-amino-4-methyl-. High-throughput virtual screening (HTVS) and molecular docking simulations allow researchers to predict the binding affinities and interactions between this compound and potential biological targets with remarkable accuracy. These computational methods have been instrumental in identifying promising candidates for experimental validation.

In addition to its synthetic utility, 3-Pyridinemethanol, 5-amino-4-methyl- has shown promise in preclinical studies as a lead compound for therapeutic intervention. Initial investigations have revealed that derivatives derived from this scaffold exhibit inhibitory activity against various enzymes implicated in diseases such as cancer and inflammation. The ability to modulate these enzymatic pathways could lead to novel therapeutic strategies with fewer side effects compared to existing treatments.

The synthesis of 3-Pyridinemethanol, 5-amino-4-methyl- itself is an intriguing challenge that has been addressed through multiple synthetic routes. Traditional methods often involve multi-step sequences requiring careful control over reaction conditions to ensure high yields and purity. However, recent innovations in synthetic methodologies have streamlined these processes, making it more feasible to produce this compound on an industrial scale.

The versatility of 3-Pyridinemethanol, 5-amino-4-methyl- extends beyond its role as an intermediate; it also serves as a model system for understanding structure-function relationships in drug design. By studying how modifications at specific positions affect biological activity, researchers can gain deeper insights into the principles governing molecular recognition and drug efficacy.

The future prospects for 3-Pyridinemethanol, 5-amino-4-methyl- are bright, with ongoing research focusing on expanding its applications across multiple therapeutic areas. As our understanding of disease mechanisms evolves, so too will our ability to harness this compound's potential through innovative chemical synthesis and drug development strategies.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)